Cell-Cycle Distribution of CD34+ Cells
| Source of Cells . | % G0 . | % G1 . | % S . | % G2M . | RNA-IG1 . | % APO . |
|---|---|---|---|---|---|---|
| BM (D0) | 22.8 ± 7 | 61.9 ± 6 | 13.8 ± 2 | 1.7 ± 0.5 | 20.3 ± 0.7 | 3.7 ± 1 |
| BM (D5) | 20.3 ± 10 | 48 ± 44-150 | 26 ± 44-150 | 3 ± 14-150 | 21.6 ± 5 | 2 ± 14-150 |
| PB (D5) | 19.2 ± 4 | 80 ± 5*† | 0.6 ± 0.3*† | 0.1 ± 0.1*† | 16.3 ± 0.5*† | 2.4 ± 0.54-150 |
| Source of Cells . | % G0 . | % G1 . | % S . | % G2M . | RNA-IG1 . | % APO . |
|---|---|---|---|---|---|---|
| BM (D0) | 22.8 ± 7 | 61.9 ± 6 | 13.8 ± 2 | 1.7 ± 0.5 | 20.3 ± 0.7 | 3.7 ± 1 |
| BM (D5) | 20.3 ± 10 | 48 ± 44-150 | 26 ± 44-150 | 3 ± 14-150 | 21.6 ± 5 | 2 ± 14-150 |
| PB (D5) | 19.2 ± 4 | 80 ± 5*† | 0.6 ± 0.3*† | 0.1 ± 0.1*† | 16.3 ± 0.5*† | 2.4 ± 0.54-150 |
The results are expressed as the mean ± SEM of 12 different experiments. RNA-IG1 defines the RNA content of G1 cells and it is determined as the ratio of the mean of RNA content of G1 cells of study samples times 10, divided by the median RNA content of control lymphocytes.
Abbreviation: APO, apoptotic.
Statistically significant versus baseline BM (D0) samples.
Statistically significant versus day-5 BM (D5) samples.